INTRODUCTIONAsthma is a complex heterogeneous respiratory disease characterized by variable airflow limitation and/or airway hyperresponsiveness. The disease is among the most common chronic illnesses in the human experience, affecting about 300 million people worldwide. The incidence of new‐onset adult asthma appears on the rise in industrialized countries, with estimates ranging from <1 to 11 cases per 1000 person‐year among published reports, but settling on about 2 per 1000 person‐years among persons aged 20‐50 years in large prospective studies. The broad category of work‐related asthma comprises adult onset asthma cases that are either caused by workplace exposures (ie, occupational asthma) or are a preexisting disease that is worsened by work factors (work‐exacerbated asthma). Estimates of the fraction of adult asthma that is work‐related have widely varied, but typically range between 10 and 25% in industrialized countries.De novo occupational asthma (OA) is induced via sensitization to a specific substance in the workplace, or by exposure to an inhaled irritant at work. There are over 300 causal agents for OA, which are broadly separated into proteinaceous substances (eg, natural rubber latex, enzymes, and animal‐derived antigens), and low‐molecular weight (LMW) chemicals (eg, isocyanates and acid anhydrides). Among known LMW agents, isocyanates, such as
American Journal of Industrial Medicine – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera